H3K18 lactylation marks tissue‑specific active enhancers
Metadata
Show full item recordEditorial
BMC
Materia
Lactylation H3K18la Lactate Epigenetics Embryonic stem cell Macrophage Adipocyte CUT&Tag ChromHMM Histone post-translational modification Promoter Enhancer
Date
2022-10-03Referencia bibliográfica
Galle, E... [et al.]. H3K18 lactylation marks tissue-specific active enhancers. Genome Biol 23, 207 (2022). [https://doi.org/10.1186/s13059-022-02775-y]
Sponsorship
ETH Zurich ETH Zurich core funding; European Research Council (ERC) European Commission 803491; Botnar Research Centre for Child Health Multi-Investigator Project; World Food System Center of ETH Zurich; Integrative Food and Nutrition Center of EPFLAbstract
Background: Histone lactylation has been recently described as a novel histone posttranslational
modification linking cellular metabolism to epigenetic regulation.
Results: Given the expected relevance of this modification and current limited knowledge
of its function, we generate genome-wide datasets of H3K18la distribution in various
in vitro and in vivo samples, including mouse embryonic stem cells, macrophages,
adipocytes, and mouse and human skeletal muscle. We compare them to profiles of
well-established histone modifications and gene expression patterns. Supervised and
unsupervised bioinformatics analysis shows that global H3K18la distribution resembles
H3K27ac, although we also find notable differences. H3K18la marks active CpG islandcontaining
promoters of highly expressed genes across most tissues assessed, including
many housekeeping genes, and positively correlates with H3K27ac and H3K4me3
as well as with gene expression. In addition, H3K18la is enriched at active enhancers
that lie in proximity to genes that are functionally important for the respective tissue.
Conclusions: Overall, our data suggests that H3K18la is not only a marker for active
promoters, but also a mark of tissue specific active enhancers.